Bernard Horn invests in Eastman Chemical, boosting stock confidence
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 17 2026
0mins
Should l Buy EMN?
Source: Coinmarketcap
Eastman Chemical Co (NYSE:EMN) saw a price increase of 5.01% as it crossed above its 20-day SMA, reflecting positive market conditions.
The stock's rise is attributed to Bernard Horn's recent investment, where he purchased 82,300 shares for a total of $6,281,140, indicating strong confidence in Eastman's growth potential. This significant investment represents 1.28% of his portfolio, suggesting a bullish outlook on the company's future performance.
Horn's investment could signal to other investors that Eastman Chemical is poised for growth, potentially attracting more interest and further driving the stock price upward.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EMN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EMN
Wall Street analysts forecast EMN stock price to rise
11 Analyst Rating
6 Buy
5 Hold
0 Sell
Moderate Buy
Current: 73.090
Low
70.00
Averages
74.40
High
80.00
Current: 73.090
Low
70.00
Averages
74.40
High
80.00
About EMN
Eastman Chemical Company is a global specialty materials company that produces a range of products found in items people use every day. Its segments include Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma, and consumables end-markets. AFP segment manufactures materials for products in food, feed, and agriculture; transportation; water treatment and energy; personal care and wellness; building and construction; consumables, and durables and electronics end-markets. The CI segment sells intermediates for end-markets, such as industrial chemicals and processing, building and construction, health and wellness, and food and feed. Its Fibers segment manufactures and sells acetate tow and triacetin plasticizers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Revenue Growth Outlook: Eastman Chemical showcased strong revenue growth associated with its new methanolysis platform, while overall market demand remained relatively unchanged, with management projecting earnings per share to exceed $6 in 2026, indicating confidence in future growth.
- Pricing Strategy Adjustments: The company anticipates mid-single-digit price increases in its specialty products, while chemical intermediates pricing is approaching 20%, reflecting proactive strategies in addressing cost inflation and supply tightness.
- Financial Results Overview: In Q1, the company recognized approximately $20 million in IEEPA tariff refunds, expected to receive cash in the second half of the year, which aligns with the impact of the winter storm, demonstrating robust financial management.
- Market Risk Assessment: Management expressed caution regarding market outlook, noting that consumer discretionary demand for durables remains pressured, and highlighted logistics risks in the Middle East that could negatively impact the Fibers business, showcasing the company's strategies in navigating uncertainty.
See More
- Small-Cap Outlook: State Street forecasts a 7.6% annual return for the S&P Small-Cap 600 index over the next three to five years, indicating a potential outperformance of small-cap stocks in the current market environment, which may attract investor interest.
- Emerging Markets Potential: The MSCI Emerging Markets index is projected to return 7.5% annually, primarily driven by U.S. dollar devaluation and strong earnings growth, providing investors with opportunities through the iShares MSCI Emerging Markets ETF.
- Expense Ratio Analysis: The Vanguard S&P Small-Cap 600 ETF has an expense ratio of 0.07%, which, while below the average for U.S. index funds, is still higher than the 0.03% expense ratio of the Vanguard S&P 500 ETF, prompting investors to consider the impact of fees on long-term returns.
- Performance Comparison: Over the past decade, the Vanguard S&P Small-Cap 600 ETF returned 180% (10.8% annually), while the S&P 500 posted a total return of 315% (15.2% annually), highlighting the relative disadvantage of small-cap stocks in a high-interest-rate environment, with future performance dependent on interest rate fluctuations.
See More
- Atlassian's Optimistic Guidance: Atlassian shares surged 23% after projecting a 24% revenue growth for the year, exceeding its previous 22% forecast and the FactSet consensus of 22.2%, indicating strong market performance and growth potential.
- nVent Electric's Strong Earnings: nVent's stock jumped 11% as first-quarter EPS and revenue surpassed Wall Street's highest estimates, with full-year revenue growth forecasted at 26% to 28%, significantly above the consensus of 18%, reflecting robust demand in data centers and energy storage.
- Cboe Global Markets Layoffs: Cboe shares rose 9% following the announcement of a 20% workforce reduction, with first-quarter adjusted EPS at $3.70 and revenue of $728.9 million, both exceeding market expectations, demonstrating the company's commitment to operational optimization.
- Roku's Revenue Beat: Roku's stock increased by 4% after reporting first-quarter revenue of $1.25 billion, surpassing the expected $1.20 billion, with adjusted EBITDA also exceeding estimates, showcasing the company's ongoing growth potential in the streaming market.
See More
- New Stock Purchases: Bernard Horn added 82,300 shares of Eastman Chemical Co (NYSE:EMN) in Q1 2026, with a total investment of $6,281,140, representing 1.28% of his portfolio, indicating confidence in the company's growth potential.
- Key Position Increases: Horn increased his stake in LATAM Airlines Group SA (XSGO:LTM) by 142,817,300 shares, a 107.91% increase, bringing total holdings to 275,167,800 shares, despite only a 0.72% portfolio impact, reflecting optimism about the airline industry's recovery.
- Complete Exits: Horn fully exited four holdings in Q1 2026, notably selling all 33,200 shares of Capgemini SE (XPAR:CAP), resulting in a -1.17% portfolio impact, which shows a cautious outlook on the company's future performance.
- Reduction in Underperformers: Horn reduced his position in Lundin Mining Corp (TSX:LUN) by 108,200 shares, a 46.84% decrease, impacting the portfolio by -0.49%, indicating concerns about the stock's future, especially given its -8.77% return over the past three months.
See More
- Dual Income Sources: The NDIV ETF targets over 10% annualized total income by combining high-dividend energy and natural resource stocks with covered call options, appealing to investors seeking commodity exposure without sacrificing yield.
- Distribution History Volatility: Monthly distributions ranged from $0.11 to $0.17 in 2024 and 2025, while February and March 2026 saw spikes to $0.27 and $0.30, reflecting income fluctuations directly tied to energy market volatility.
- Commodity Volatility Dependency: NDIV's income is contingent on market volatility; while the covered call strategy enhances income during high volatility, it also introduces uncertainty regarding dividends from holdings like Petrobras and LyondellBasell.
- Price Performance and Yield: NDIV shares have appreciated approximately 34% year-to-date and about 44% over the past year, indicating that investors have captured significant capital gains alongside income, with a current dividend yield near 5%.
See More
- Infleqtion Coverage Initiation: Citigroup initiates coverage of quantum computing firm Infleqtion with a Buy/High Risk rating and a $20 price target, highlighting its uniqueness in the quantum computing sector, which may attract investor interest.
- SAP Downgrade: Piper Sandler downgrades SAP from Overweight to Neutral, citing challenges in the macroeconomic environment and anticipating lower valuation multiples as the software industry transitions from SaaS to AI.
- Positive Catalysts for Alphabet: Citigroup adds a 90-day Catalyst Watch on Alphabet, expecting upcoming product updates during events like Google Cloud Next and YouTube Brandcast to drive stock price appreciation.
- Biogen Upgrade: Piper Sandler upgrades Biogen from Neutral to Overweight, raising the price target from $177 to $214, reflecting confidence in its growth potential moving forward.
See More











